Biofidelity
Last verified 2026-05-17. JSON
The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.
| Total raised | $23.8Mattributed |
|---|---|
| Latest round | series-a, $23.8M, 2024-04-01attributed |
| Founded | 2018 |
| Headquarters | Cambridge, UK |
| Industry | bio |
| Stage | series-a |
| Website | biofidelity.com |
Aspyre Lung clinical test profiles 11 NSCLC genes from DNA and RNA in tissue or blood with next-day turnaround. Used by oncologists and pathology labs that need rapid molecular profiling for non-small-cell lung cancer. Detects mutations and gene fusions in a single workflow on samples with as little as 10% tumour content.
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2024-04-01 | series-a | $23.8M | undisclosed |
Detected tech stack
Cloudflare, Linkedin Ads, Linkedin Insight Tag, Google Analytics, Google Tag Manager, Slick, jQuery Migrate 3.4.1, DoubleClick Floodlight, HubSpot, Cloudflare Bot Management, WordPress, WordPress Block Editor
Provenance
| Fact | Status | Basis |
|---|---|---|
| Series A, $23.8M | attributed | sifted named as publisher. No document URL on file. |
| Total raised $23.8M | attributed | sifted named as publisher. No document URL on file. |
| Company existence | self-reported | biofidelity.com, read 2026-05-17 |
| Description | self-reported | biofidelity.com, read 2026-05-17 |
Nothing on this page is sourced yet. A sourced fact links to a document that states it.
Change history
No change recorded since records began on 2026-09-24.